Identifying serum lipidomic signatures related to prognosis in first-episode schizophrenia
Abstract Background Antipsychotic medications are crucial for alleviating symptoms of schizophrenia (SCZ). However, treatment responses vary across individuals, and few reliable biomarkers currently exist to predict the clinical outcome. Therefore, we aim to identify potential lipid markers for trea...
Saved in:
| Main Authors: | Mengyi Luo, Suzhen Zhang, Jingxin Xue, Tianhao Gao, Xuan Li, Zhaolin Zhai, Chang Lu, Yuke Dong, Kaiming Zhuo, Qiong Xiang, Qing Kang, Shunying Yu, Chunhong Shao, Dengtang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Psychiatry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12888-025-06802-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of corpus callosum lipidome and transcriptome in schizophrenia and healthy brain
by: Maria S. Osetrova, et al.
Published: (2025-04-01) -
Uncovering metabolic dysregulation in schizophrenia and cannabis use disorder through untargeted plasma lipidomics
by: Aitor Villate, et al.
Published: (2024-12-01) -
Deep brain stimulation of Hippocampus in Treatment-resistant Schizophrenia (DBS-HITS): protocol for a crossover randomized controlled trial
by: Chang Lu, et al.
Published: (2024-11-01) -
First episode schizophrenia
by: Nadira Khamker
Published: (2015-09-01) -
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
by: Sijia He, et al.
Published: (2025-01-01)